M. Narita et al., Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts, BR J HAEM, 105(4), 1999, pp. 928-937
The t(10;11)(p13-14;q14-21) is a rare but recurring translocation associate
d with acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML
). Recently the CALM gene was cloned from the t(10:11) breakpoint of U937 a
nd fused to AF10, a putative transcription factor, which had been identifie
d as one of the fusion partners of the MLL gene. In order to define the inv
olvement of these genes in primary leukaemias and cell lines with t(10;11),
we analysed the expression of fusion transcripts by reverse transcriptase-
polymerase chain reaction (RT-PCR) in five patient samples including ALL, A
ML and lymphoblastic lymphoma, and three monocytic cell lines (P31/Fujioka,
KP-Mo-TS and U937. The CALM-AF10 fusion transcript was detected in all sam
ples: however, the AF10-CALM fusion was not detected in two patient samples
and one cell line. In RT-PCR analysis there were six Isoforms of the CALM-
AF10 fusion. transcripts and five of AF10-CALM fusion transcripts, We also
detected novel transcripts in U937, Sequence analysis revealed that all the
se isoforms had in-frame junctions and that some of them resulted from alte
rnative splicing at different exons of CALM and others from different break
points at CALM and/or AF10, There were at least two different breakpoints o
f CALM and three of AF10 gene. Our results suggest that the CALM-AF10 fusio
n gene is a constant feature and is involved in the pathogenesis of haemato
logical malignancies with t(10;11)/p13-14;q14-21), shelving various and oft
en multilineage phenotypes. Thus, t(10;11) needs to be investigated by RT-P
CR for identification of the genes involved.